ArticleClinical and experimental immunology2025

Immunomodulatory effects of HYCO-3, a dual action CO-releaser/Nrf2 activator.

Goran Stegnjaić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.